Next Article in Journal
Supercritical Carbon Dioxide Extraction of the Oak Silkworm (Antheraea pernyi) Pupal Oil: Process Optimization and Composition Determination
Previous Article in Journal
Antioxidant and Hepatoprotective Effects of the Red Ginseng Essential Oil in H2O2-Treated HepG2 Cells and CCl4-Treated Mice
Previous Article in Special Issue
Tumor Heterogeneity: Mechanisms and Bases for a Reliable Application of Molecular Marker Design

Epigenetic Disregulation in Oral Cancer

Department of Biomorphological and Functional Sciences, Pathology Section, University of Naples “Federico II”, Naples 80131, Italy
Centro di Riferimento Oncologico di Basilicata (C.R.O.B.) Oncology Research Center of Basilicata, Rionero in Vulture, Potenza 85028, Italy
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2012, 13(2), 2331-2353;
Received: 6 December 2011 / Revised: 9 February 2012 / Accepted: 13 February 2012 / Published: 21 February 2012
(This article belongs to the Special Issue Advances in Molecular Pathology)
Squamous cell carcinoma of the oral region (OSCC) is one of the most common and highly aggressive malignancies worldwide, despite the fact that significant results have been achieved during the last decades in its detection, prevention and treatment. Although many efforts have been made to define the molecular signatures that identify the clinical outcome of oral cancers, OSCC still lacks reliable prognostic molecular markers. Scientific evidence indicates that transition from normal epithelium to pre-malignancy, and finally to oral carcinoma, depends on the accumulation of genetic and epigenetic alterations in a multistep process. Unlike genetic alterations, epigenetic changes are heritable and potentially reversible. The most common examples of such changes are DNA methylation, histone modification, and small non-coding RNAs. Although several epigenetic changes have been currently linked to OSCC initiation and progression, they have been only partially characterized. Over the last decade, it has been demonstrated that especially aberrant DNA methylation plays a critical role in oral cancer. The major goal of the present paper is to review the recent literature about the epigenetic modifications contribution in early and later phases of OSCC malignant transformation; in particular we point out the current evidence of epigenetic marks as novel markers for early diagnosis and prognosis as well as potential therapeutic targets in oral cancer. View Full-Text
Keywords: epigenetics; oral cancer; tumor progression; prognosis; molecular therapy epigenetics; oral cancer; tumor progression; prognosis; molecular therapy
Show Figures

MDPI and ACS Style

Mascolo, M.; Siano, M.; Ilardi, G.; Russo, D.; Merolla, F.; Rosa, G.D.; Staibano, S. Epigenetic Disregulation in Oral Cancer. Int. J. Mol. Sci. 2012, 13, 2331-2353.

AMA Style

Mascolo M, Siano M, Ilardi G, Russo D, Merolla F, Rosa GD, Staibano S. Epigenetic Disregulation in Oral Cancer. International Journal of Molecular Sciences. 2012; 13(2):2331-2353.

Chicago/Turabian Style

Mascolo, Massimo; Siano, Maria; Ilardi, Gennaro; Russo, Daniela; Merolla, Francesco; Rosa, Gaetano De; Staibano, Stefania. 2012. "Epigenetic Disregulation in Oral Cancer" Int. J. Mol. Sci. 13, no. 2: 2331-2353.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop